Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Frequency Therapeutics, Inc. (FREQ) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/25/2020 4 FELDMANN CYNTHIA L (Director) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 29,693 options @ $20.37, valued at $604.8k
09/25/2020 3 FELDMANN CYNTHIA L (Director) has filed a Form 3 on Frequency Therapeutics, Inc.
09/25/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : September 23, 2020 FREQUENCY THERAPEUTICS, INC. Delaware 001-39062 47-2324450 19 Presidential Way, 2nd Floor Woburn, MA 01801 389-1970 N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 un...",
"Amended and Restated Bylaws of Frequency Therapeutics, Inc., effective as of September 23, 2020",
"Frequency Therapeutics Appoints Cynthia Feldmann to its Board of Directors"
09/25/2020 4 Loose Christopher R. (Chief Scientific Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Sold 1,870 shares @ $20.5121, valued at $38.4k
Sold 2,606 shares @ $21.566, valued at $56.2k
Sold 24 shares @ $22.43, valued at $538.3
09/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/04/2020 EFFECT Form EFFECT - Notice of Effectiveness:
09/03/2020 4 Lucchino David L. (President and CEO) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Sold 12,128 shares @ $18.4, valued at $223.2k
Sold 3,586 shares @ $19.0514, valued at $68.3k
08/28/2020 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
08/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/12/2020 10-Q Quarterly Report for the period ended June 30, 2020
08/12/2020 8-K Quarterly results
08/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/05/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2020 D Form D - Notice of Exempt Offering of Securities:
07/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2020 8-K Quarterly results
07/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/12/2020 4 Loose Christopher R. (Chief Scientific Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Sold 4,500 shares @ $19.962, valued at $89.8k
06/12/2020 8-K Submission of Matters to a Vote of Security Holders
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : June 11, 2020 FREQUENCY THERAPEUTICS, INC. Delaware 001-39062 47-2324450 19 Presidential Way, 2nd Floor Woburn, MA 01801 389-1970 N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under t..."
06/12/2020 4 MARCUS JOEL S (Director) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 14,846 options @ $18.63, valued at $276.6k
06/12/2020 4 LANGER ROBERT (Director) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 14,846 options @ $18.63, valued at $276.6k
06/12/2020 4 BARBERICH TIMOTHY J (Director) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 14,846 options @ $18.63, valued at $276.6k
06/12/2020 4 COHEN MARC A (Director) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 14,846 options @ $18.63, valued at $276.6k
06/12/2020 4 Huang Michael (Director) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Granted 14,846 options @ $18.63, valued at $276.6k
06/04/2020 4 Mitrano Richard J. (VP Finance & Operations) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Exercised 929 options @ $0.07, valued at $65
Exercised 2,552 options @ $0.61, valued at $1.6k
06/04/2020 4 Lucchino David L. (President and CEO) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Sold 3,839 shares @ $18.5664, valued at $71.3k
06/02/2020 4 Lucchino David L. (President and CEO) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Sold 11,875 shares @ $17.9077, valued at $212.7k
05/22/2020 4 Loose Christopher R. (Chief Scientific Officer) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Sold 2,668 shares @ $18.8164, valued at $50.2k
Sold 1,832 shares @ $19.3277, valued at $35.4k
05/22/2020 4 MARCUS JOEL S (Director) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Sold 5,000 shares @ $18.8105, valued at $94.1k
05/20/2020 4 MARCUS JOEL S (Director) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns: Sold 15,000 shares @ $19.1459, valued at $287.2k
Sold 7,809 shares @ $18.3981, valued at $143.7k
Sold 5,000 shares @ $18.7591, valued at $93.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy